Showing results (461-470 of 2,012) with videos related to
Sort By:
Pageof 202
Annals of Hepatology|November 7, 2025
Involvement of the hedgehog signaling pathway in liver diseasesKarla Jocelyn Ortega-Carballo, Eduardo Enrique Vargas-Pozada, Pablo MurielAnnals of Hepatology|October 11, 2025
Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyZiming Zheng, Yumei Huang, Jijuan Zhang, et al.Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.Annals of Hepatology|May 18, 2025
Non-alcoholic fatty liver disease, in contrast to alcoholic liver disease, is associated with lower socio-economic status: results from a German referral centerSemjon Bugaichuk, Verena Wilkens, Karoline Horvatits, et al.Annals of Hepatology|May 10, 2025
Development of a prediction index for persistent acute kidney injury following orthotopic liver transplantNoemi Del Toro-Cisneros, Francisco Javier Antiga-López, Karina C Felix-Bauer, et al.Annals of Hepatology|May 24, 2025
Acute kidney injury incidence and clinical features: Refractory versus non-refractory ascitesNeha Tiwari, Chinmay Bera, Nazia Selzner, et al.Annals of Hepatology|May 25, 2025
A global comparison of hepatitis B & C drug pricingLeah Yao, Xiaohan Ying, Getan Malik, et al.Annals of Hepatology|June 3, 2025
Data mining reveals novel gene drivers of lenvatinib resistance in hepatocellular carcinomaCyrollah Disoma, Claudio Tiribelli, Caecilia SukowatiAnnals of Hepatology|April 27, 2025
Development and evaluation of percentile curves of serum alanine aminotransferase in older adults: A multi-cohort studyYu Zhang, Shuwen Li, Kang Fu, et al.Annals of Hepatology|October 25, 2025
Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990-2050Yujiao Deng, Jingyue Tan, Jian Zu, et al.Pageof 202